Clinical Trial Update: A Phase III Study Evaluate the Efficacy and Safety of BAT1406 and Humira [Phase 3]

View source ↗

Summary

Phase III trial evaluating BAT1406 compared with Humira in ankylosing spondylitis has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Ankylosing Spondylitis

Drugs mentioned

• BAT1406
• Humira (adalimumab)

Snippet

Sponsor: Bio-Thera Solutions | Conditions: Ankylosing Spondylitis | Phase 3 | Status: COMPLETED